Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Jun;45(2):299–310. doi: 10.1111/j.1476-5381.1972.tb08084.x

The inactivation of bradykinin in the pulmonary circulation of isolated lungs

Valerie A Alabaster, Y S Bakhle
PMCID: PMC1666127  PMID: 4625922

Abstract

1. The isolated lungs of guinea-pigs, rats and dogs, perfused with Krebs bicarbonate solution via the pulmonary artery, inactivated 95, 98 and 99% respectively of the bradykinin infused through them.

2. This inactivation process was not inhibited by 2-mercaptoethanol (1 mM) or EDTA (500 μM).

3. The inactivation was inhibited by 2:3-dimercaptopropanol (100 μM), N-ethylmaleimide (100 μM), and several of the bradykinin potentiating peptides from Bothrops jararaca, in both natural and synthetic forms.

4. The effect of these compounds, 2-mercaptoethanol, EDTA, 2:3-dimercaptopropanol, N-ethylmaleimide and Bothrops peptides on the pulmonary bradykininase activity is the same as their effect on pulmonary angiotensin I converting enzyme.

Full text

PDF
299

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alabaster V. A., Bakhle Y. S. Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1970 Nov;40(3):468–482. [PMC free article] [PubMed] [Google Scholar]
  2. BUMPUS F. M., SMEBY R. R., PAGE I. H., KHAIRALLAH P. A. DISTRIBUTION AND METABOLIC FATE OF ANGIOTENSIN II AND VARIOUS DERIVATIVES. Can Med Assoc J. 1964 Jan 25;90:190–193. [PMC free article] [PubMed] [Google Scholar]
  3. Bakhle Y. S. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature. 1968 Nov 30;220(5170):919–921. doi: 10.1038/220919a0. [DOI] [PubMed] [Google Scholar]
  4. Bakhle Y. S. Inhibition of angiotensin I converting enzyme by venom peptides. Br J Pharmacol. 1971 Sep;43(1):252–254. doi: 10.1111/j.1476-5381.1971.tb07176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bakhle Y. S., Reynard A. M. Characteristics of the angiotensin I converting enzyme from dog lung. Nat New Biol. 1971 Feb 10;229(6):187–189. doi: 10.1038/newbio229187a0. [DOI] [PubMed] [Google Scholar]
  6. Bakhle Y. S., Reynard A. M., Vane J. R. Metabolism of the angiotensins in isolated perfused tissues. Nature. 1969 Jun 7;222(5197):956–959. doi: 10.1038/222956a0. [DOI] [PubMed] [Google Scholar]
  7. Biron P. Pulmonary extractionof bradykinin and eledoisin. Rev Can Biol. 1968 Mar;27(1):75–76. [PubMed] [Google Scholar]
  8. ERDOS E. G., SLOANE E. M. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol. 1962 Jul;11:585–592. doi: 10.1016/0006-2952(62)90119-3. [DOI] [PubMed] [Google Scholar]
  9. FERREIRA S. H. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965 Feb;24:163–169. doi: 10.1111/j.1476-5381.1965.tb02091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferreira S. H., Bartelt D. C., Greene L. J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry. 1970 Jun 23;9(13):2583–2593. doi: 10.1021/bi00815a005. [DOI] [PubMed] [Google Scholar]
  11. Ferreira S. H., Rocha e Silva M. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia. 1965 Jun 15;21(6):347–349. doi: 10.1007/BF02144709. [DOI] [PubMed] [Google Scholar]
  12. Ferreira S. H., Vane J. R. The detection and estimation of bradykinin in the circulating blood. Br J Pharmacol Chemother. 1967 Mar;29(3):367–377. doi: 10.1111/j.1476-5381.1967.tb01968.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferreira S. H., Vane J. R. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol Chemother. 1967 Jun;30(2):417–424. doi: 10.1111/j.1476-5381.1967.tb02148.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gruby L. A., Rowlands C., Varley B. Q., Wyllie J. H. The fate of 5-hydroxytryptamine in the lungs. Br J Surg. 1971 Jul;58(7):525–532. doi: 10.1002/bjs.1800580716. [DOI] [PubMed] [Google Scholar]
  15. Iwata H., Shikimi T., Oka T. Pharmacological significances of peptidase and proteinase in the brain. I. Enzymatic inactivation of bradykinin in rat brain. Biochem Pharmacol. 1969 Jan;18(1):119–128. doi: 10.1016/0006-2952(69)90016-1. [DOI] [PubMed] [Google Scholar]
  16. MANN M., WEST G. B. The nature of hepatic and splenic sympathin. Br J Pharmacol Chemother. 1950 Jun;5(2):173–177. doi: 10.1111/j.1476-5381.1950.tb01004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969 Jul 5;223(5201):29–35. doi: 10.1038/223029a0. [DOI] [PubMed] [Google Scholar]
  18. Pojda S. M., Vane J. R. Inhibitory effects of aprotinin on kallikrein and kininases in dog's blood. Br J Pharmacol. 1971 Aug;42(4):558–568. doi: 10.1111/j.1476-5381.1971.tb07140.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ryan J. W., Roblero J., Stewart J. M. Inactivation of bradykinin in the pulmonary circulation. Biochem J. 1968 Dec;110(4):795–797. doi: 10.1042/bj1100795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scholz H. W., Biron P. Non-identity between pulmonary bradykininase and converting-enzyme activity. Rev Can Biol. 1969 Sep;28(3):197–200. [PubMed] [Google Scholar]
  21. Suzuki K., Abinko T., Endo N., Kameyama T., Sasaki K. Biologically active synthetic fragments of bradykinin. Jpn J Pharmacol. 1969 Jun;19(2):325–327. doi: 10.1254/jjp.19.325. [DOI] [PubMed] [Google Scholar]
  22. Yang H. Y., Erdös E. G., Levin Y. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J Pharmacol Exp Ther. 1971 Apr;177(1):291–300. [PubMed] [Google Scholar]
  23. Yang H. Y., Erdös E. G. Second kininase in human blood plasma. Nature. 1967 Sep 23;215(5108):1402–1403. doi: 10.1038/2151402a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES